Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 353

1.
2.

Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Miettinen M, Sobin LH, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.

PMID:
19440146
4.

Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.

Kang DY, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM.

Am J Surg Pathol. 2007 Feb;31(2):224-32.

PMID:
17255767
6.

Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, Yokoyama S, Motegi A, Fukayama M.

Am J Surg Pathol. 2005 Jun;29(6):755-63.

PMID:
15897742
7.

Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases.

Lasota J, Corless CL, Heinrich MC, Debiec-Rychter M, Sciot R, Wardelmann E, Merkelbach-Bruse S, Schildhaus HU, Steigen SE, Stachura J, Wozniak A, Antonescu C, Daum O, Martin J, Del Muro JG, Miettinen M.

Mod Pathol. 2008 Apr;21(4):476-84. doi: 10.1038/modpathol.2008.2. Epub 2008 Feb 1.

8.

Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study.

Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR.

Mod Pathol. 2005 Apr;18(4):475-84.

9.

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.

Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, De Wever I, Vermeesch JR, de Raedt T, De Paepe A, Speleman F, van Oosterom A, Messiaen L, Legius E.

Hum Mol Genet. 2006 Mar 15;15(6):1015-23. Epub 2006 Feb 6.

PMID:
16461335
10.

KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).

Lasota J, Miettinen M.

Semin Diagn Pathol. 2006 May;23(2):91-102. Review.

PMID:
17193822
11.

Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.

Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P.

Clin Cancer Res. 2008 Jul 15;14(14):4550-5. doi: 10.1158/1078-0432.CCR-08-0086.

12.

NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG.

Am J Surg Pathol. 2005 Sep;29(9):1170-6.

PMID:
16096406
14.

KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.

Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y.

Am J Surg Pathol. 2011 Sep;35(9):1287-95. doi: 10.1097/PAS.0b013e3182206f15.

PMID:
21836495
15.

Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.

de Raedt T, Cools J, Debiec-Rychter M, Brems H, Mentens N, Sciot R, Himpens J, de Wever I, Schöffski P, Marynen P, Legius E.

Gastroenterology. 2006 Dec;131(6):1907-12.

PMID:
17087943
16.

Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases.

Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J.

Am J Surg Pathol. 2003 May;27(5):625-41.

PMID:
12717247
17.

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors.

Lasota J, vel Dobosz AJ, Wasag B, Wozniak A, Kraszewska E, Michej W, Ptaszynski K, Rutkowski P, Sarlomo-Rikala M, Steigen SE, Schneider-Stock R, Stachura J, Chosia M, Ogun G, Ruka W, Siedlecki JA, Miettinen M.

Lab Invest. 2007 Oct;87(10):1029-41. Epub 2007 Jul 16.

18.
19.

The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).

Du CY, Shi YQ, Zhou Y, Fu H, Zhao G.

J Surg Oncol. 2008 Sep 1;98(3):175-8. doi: 10.1002/jso.21104.

PMID:
18618605
20.

Supplemental Content

Support Center